» Articles » PMID: 22429348

Growth Inhibition of Malignant Melanoma by Intermediate Frequency Alternating Electric Fields, and the Underlying Mechanisms

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2012 Mar 21
PMID 22429348
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study investigated the antitumour effects of intermediate frequency alternating electric fields (IF-AEF) in a murine melanoma cell line (B16F10) and a mouse tumour model.

Methods: IF-AEF was applied at 100 kHz. Proliferation of B16F10 cells in vitro was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. IF-AEF was applied in vivo to mice bearing B16F10 tumours. Terminal deoxy nucleotidyl transferase-mediated dUTP nick end labelling (TUNEL) assay for apoptosis, and immunohistochemical detection of CD34 and vascular endothelial growth factor (VEGF), were performed.

Results: IF-AEF inhibited the proliferation of B16F10 cells in an electrical intensity and time-dependent manner. Treatment with IF-AEF for 7 days significantly inhibited the growth of tumours compared with untreated controls. IF-AEF induced apoptosis in vivo and reduced CD34-positive cell numbers; CD34 is a special marker of microvessel density.

Conclusion: IF-AEF reduced microvessel density related to tumour growth and may serve as a therapeutic strategy for cancer treatment.

Citing Articles

Tumor-treating fields in cancer therapy: advances of cellular and molecular mechanisms.

Xiao T, Zheng H, Zu K, Yue Y, Wang Y Clin Transl Oncol. 2024; 27(1):1-14.

PMID: 38884919 DOI: 10.1007/s12094-024-03551-z.


Theory and application of TTFields in newly diagnosed glioblastoma.

Yu A, Zeng J, Yu J, Cao S, Li A CNS Neurosci Ther. 2024; 30(3):e14563.

PMID: 38481068 PMC: 10938032. DOI: 10.1111/cns.14563.


The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy.

Tanzhu G, Chen L, Xiao G, Shi W, Peng H, Chen D Cell Death Discov. 2022; 8(1):416.

PMID: 36220835 PMC: 9553876. DOI: 10.1038/s41420-022-01206-y.


Tumor-Treating Fields in Glioblastomas: Past, Present, and Future.

Guo X, Yang X, Wu J, Yang H, Li Y, Li J Cancers (Basel). 2022; 14(15).

PMID: 35954334 PMC: 9367615. DOI: 10.3390/cancers14153669.


Tumor Treating Fields: At the Crossroads Between Physics and Biology for Cancer Treatment.

Carrieri F, Smack C, Siddiqui I, Kleinberg L, Tran P Front Oncol. 2020; 10:575992.

PMID: 33215030 PMC: 7664989. DOI: 10.3389/fonc.2020.575992.